Shanghai De Novo Pharmatech is a clinical stage biotech company. Building on our extensive in-house capability in pharmaceutical chemistry and translational medicine, we have established an internationally competitive oncology pipeline, with two leading innate immune agonists at clinical stage. 

To widen therapeutic window by deliver immune agoinst precisely, we are in the process of building an ISAC technology platform, two ISAC drug candidates are in discovery stage now.